Webinar: Nanovaccine Institute series

Su Mo Tu We Th Fr Sa
26 27 28 29 30 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6
Date/Time:Thursday, 28 Oct 2021 from 3:00 pm to 4:00 pm
Location:Online
Cost:Free
URL:www.nanovaccine.iastate.edu
Contact:
Phone:515-294-2194
Channel:Research
Categories:Lectures
Actions:Download iCal/vCal | Email Reminder
"Organoid as a New Platform to Develop Oral Vaccines and Nanomedicines," Qun Wang, Iowa State chemical and biological engineering.

Registration
Online registration

Zoom link
https://iastate.zoom.us/j/94852742613

About the Seminar
Organoids bridge a gap in existing model systems by providing a more stable system amenable to extended cultivation and manipulation while being more representative of in vivo physiology. Three-dimensional ex vivo organoid cultures using biomaterial-based assembly and self-assembly have been shown to resemble and recapitulate most of the functionality of diverse multicellular tissues and organs, such as the gut organoids. Moreover, the discovery of substrates, pathways, and growth factors involved in the differentiation of organoids and stem cells into specific lineages is expected to contribute significantly to the clinical protocols. Our team explored ex vivo gut organoid models to study new oral vaccine delivery systems by determining how artificial virus-like nanoparticle-based (AVN) vaccine transport within an ex vivo intestinal mucosal immunological system built by primary intestinal stem cells derived gut organoids (Miniguts). Our research showed that the mammalian orthoreovirus cell attachment protein ?1 (MRV ?1) functionalized AVNs resulted in targeted vaccine delivery through induced M-cells in the intestinal epithelium.